CLINICAL_TRIALS
withdrawal
· 2022-02-02
Clinical Trial Update: Cycled Testosterone Administration During Pulmonary Rehabilitation in Early Stage COPD [Phase 2, Phase 3]
Summary
A clinical trial investigating cycled testosterone during pulmonary rehabilitation in early-stage COPD was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: The University of Texas Medical Branch, Galveston | Conditions: COPD | Phase 2, Phase 3 | Status: WITHDRAWN